• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Microsoft Launches $40M, 5-Year Ai for Health Initiative to Advance Health Globally

Share:

February 4, 2020

Highlights on this story:
  • Microsoft launches 5-year, $40M AI for Health initiative to advance the health of people and communities around the world through artificial intelligence (AI).
  • AI for Health will focus on three core areas: quest for discovery, global health insights, and health equity.

Microsoft Corporation, today announced the launch of AI for Health, a new $40M, five-year program to empower researchers and organizations with AI to improve the health of people and communities around the world. . AI for Health is the fifth Microsoft AI for Good program, a $165 million initiative to empower researchers, nonprofits and organizations with advanced technologies to help unlock solutions to the biggest challenges facing society today.\

AI for Health Background

AI for Health is a philanthropic initiative that complements our broader work in Microsoft Healthcare. The AI for Health program will operate via collaborations that leverage our best AI tools and technical expertise from Microsoft to further quests for medical discovery, uncover global health insights and increase health equity across underserved populations.

AI for Health Initiative Key Areas

The AI for Health initiative will focus on three key areas:

1. Quest for discovery. Accelerating medical research to advance prevention, diagnoses, and treatment of diseases

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

2. Global health insights. Increasing our shared understanding of mortality and longevity to protect against global health crises

3. Health equity. Reducing health inequity and improving access to care for underserved populations

The AI for Health program will operate via collaborations that leverage our best AI tools and technical expertise from Microsoft to further quests for medical discovery, uncover global health insights and increase health equity across underserved populations. A handful of our current projects include:

Key Drivers for the AI for Health Initiative

The health of people and communities around the world has been improving over time. However, progress has not been equal across the globe, and there is a great need to focus on societal issues such as reducing health inequity and improving access to care for underserved populations. Even in countries such as the U.S. that have made great progress in reducing child mortality, the probability of a child surviving to their fifth birthday depends heavily on the zip code where that child was born and varies dramatically by demographics. While researchers work to unlock life-saving discoveries and develop new approaches to pressing health issues, advancements in technology can help accelerate and scale new solutions. This is where the AI for Health program can help.

Current Projects Underway

A handful of our current projects underway include:

– Strengthening our medical understanding of the causes and diagnosis of Sudden Infant Death Syndrome (SIDS), in collaboration with Seattle Children’s Research Institute

– Working with the Novartis Foundation to accelerate efforts to eliminate leprosy by focusing on interventions that aim to interrupt transmission

– Deploying for use in primary care end-to-end diabetic retinopathy diagnostic software, developed in partnership with Intelligent Retinal Imaging Systems (IRIS), that can help curb preventable blindness

– Exploring new ways to unlock cross-organizational access to information that can lead to breakthroughs in research by working with Fred Hutchinson Cancer Research Center and the Cascadia Data Discovery Initiative to accelerate new avenues to prevent and treat cancer

In addition, Microsoft is expanding its existing partnerships with nonprofits – BRAC, PATH, and St. Jude Children’s Research Hospital – to propel additional advancements in the important fields of maternal mortality, tuberculosis treatment, and pediatric cancer.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • XRHealth, Reducept Offer Patients Virtual Reality Therapy for Pain ManagementXRHealth, Reducept Offer Patients Virtual Reality Therapy for Pain Management
  • Sharecare Acquires Whitehatai to Provide Health Plan and Provider Clients with Additional Capabilities to Ensure Healthcare Payment IntegritySharecare Acquires Whitehatai to Provide Health Plan and Provider Clients with Additional Capabilities to Ensure Healthcare Payment Integrity
  • NeuroMetrix Signs DPNCheck® Collaboration Agreement with BiomedixNeuroMetrix Signs DPNCheck® Collaboration Agreement with Biomedix
  • Sanofi Completes Acquisition of Translate Bio, Accelerating the Application of mRNA in New Vaccines and TherapeuticsSanofi Completes Acquisition of Translate Bio, Accelerating the Application of mRNA in New Vaccines and Therapeutics
  • Why Big Pharma and biotech are betting big on AIWhy Big Pharma and biotech are betting big on AI
  • YouTube Rolls Out New Guidelines Around Vaccine MisinformationYouTube Rolls Out New Guidelines Around Vaccine Misinformation
  • Tilray, Inc. Completes Merger With Privateer Holdings, Inc.Tilray, Inc. Completes Merger With Privateer Holdings, Inc.
  • Cerner Extends On-Site & Near-Site Health Center Experience with 24/7 Digital Primary CareCerner Extends On-Site & Near-Site Health Center Experience with 24/7 Digital Primary Care

Trending This Week

  • Immuno-Oncology Pipeline Cuts Explained
  • Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
  • USFDA Accepts Glenmark’s Application to Initiate a Human Trial of Molecules for Advanced Solid Tumors and Lymphomas
  • Concentra’s Buy Offer May Jeopardize Jounce’s Merger with Redx
  • Pfizer Acquires Seagen For $43B To Tackle Cancer
  • Janssen’s Novel Dengue Antiviral Demonstrates ‘strong Protection’ in Pre-Clinical Data

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications